[Federal Register Volume 67, Number 132 (Wednesday, July 10, 2002)]
[Notices]
[Page 45764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-17212]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 27, 2002, and published in the Federal 
Register on April 10, 2002, (67 FR 17468), Cody Laboratories, Inc., 331 
33rd Street, Cody, Wyoming 82414, made application to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Hydromorphone (9150).......................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firms plans to bulk manufacture the listed controlled 
substances in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Cody Laboratories to manufacture 
the listed controlled substances is consistent with the public interest 
at this time. DEA has investigated Cody Laboratories to ensure that the 
company's registration is consistent with the public interest. This 
investigation included inspection and testing of the company's physical 
security systems, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: June 24, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-17212 Filed 7-9-02; 8:45 am]
BILLING CODE 4410-09-M